Table 2.
D Group | V Group | ||
Characteristics | n = 42 | n = 59 | P value |
Surgical information | |||
Standard lymphadenectomy | 27 (64.3%) | 34 (57.6%) | .500 |
Extended lymphadenectomy | 15 (35.7%) | 25 (42.4%) | .500 |
Blood lose, mL | 650 (200–2100) | 730 (200–2250) | .887 |
Blood transfusion | 7 (16.7%) | 12 (20.3%) | .642 |
Postoperative complications∗ | 12 (28.6%) | 18 (30.5%) | .461 |
Positive surgical margin† | 3 (7.1%) | 2 (3.4%) | .647 |
Postoperative chemotherapy | 15 (35,7%) | 19 (32.2%) | .713 |
Tumor factors | |||
Tumor size, cm‡ | 3.15 ± 0.83 | 2.72 ± 0.66 | .005 |
Vascular invasion positive | 14 (33.3%) | 22 (37.3%) | .683 |
Perineural invasion positive | 37 (88.1%) | 52 (88.1%) | .995 |
Lymph node invasion positive | 24 (57.1%) | 31 (52.5%) | .647 |
LN8, LN12 invasion positive | 19 (45.2%) | 6 (10.2%) | .001 |
LN14 invasion positive | 2 (4.8%) | 19 (32.2%) | .002 |
LN16 invasion positive | 12 (28.6%) | 13 (22.0%) | .453 |
Bile duct invasion positive | 33 (78.6%) | 35 (59.3%) | .042 |
Duodenal invasion positive | 30 (71.4%) | 26 (44.1%) | .006 |
Serosal infiltration positive | 28 (66.7%) | 47 (79.7%) | .141 |
Pathological UICC stage | .504 | ||
Ia | 2 (4.8%) | 1 (1.7%) | |
Ib | 12 (28.6%) | 25 (42.4%) | |
IIa | 3 (7.1%) | 2 (3.4%) | |
IIb | 15 (35.7%) | 21 (35.6%) | |
III | 10 (23.8%) | 10 (16.9%) |